- 3 次围观
产品图片
货号/SKU
NR-52149
货号/规格
EA
库存与交货期
3-8周
人民币价格
14000
试剂海关审批
A/B级风险物质只能直接使用人购买并持有实验室有效资质，其它询客服确认
国外采购
支持/部分限制一年内购买数量
厂牌
BEI Resources(ATCC)
产品基础信息
生物安全等级建议分类：美国、2
产品描述信息
NR-52149??Acinetobacter baumannii, MRSN 843 (Bacteria)|Acinetobacter baumannii|MRSN 843 |-60°C or colder|MRSN/WRAIRAcknowledgment for publications should read “The following reagent was obtained through BEI Resources, NIAID, NIH: Acinetobacter baumannii, Strain MRSN 843, NR-52149. This strain is part of the Acinetobacter baumannii Diversity Panel provided by the Multidrug-Resistant Organism Repository and Surveillance Network (MRSN) at the Walter Reed Army Institute of Research (WRAIR).”|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.
Acinetobacter baumannii (A. baumannii), strain MRSN 843 was isolated in 2010 from a human wound sample in the United States as part of a global surveillance program.
A. baumannii, strain MRSN 843 was deposited as part of the MRSN Acinetobacter baumannii Diversity Panel available from BEI Resources as NR-52248. NR-52149 was deposited as multi-locus sequence type (MLST) ST 417, sensitive to amikacin, ampicillin/sulbactam, cefepime, ceftazidime, colistin and imipenem, intermediately resistant to ceftriaxone and tobramycin and resistant to ciprofloxacin, gentamicin, levofloxacin, meropenem, trimethoprim/sulfamethoxazole and tetracycline. Strain MRSN 843 is reported to have an aminoglycoside transferase gene [ant(2'')-Ia; conferring resistance to various aminoglycosides], two beta-lactamase genes (blaADC-25 and blaOXA-82; conferring resistance to beta-lactams), a chloramphenicol acetyltransferase gene (catB3; conferring resistance to chloramphenicol), a dihydrofolate reductase gene (dfrA19; conferring resistance to trimethoprim), a macrolide phosphotransferase gene [mph(E); conferring resistance to macrolides], an ABC-F type ribosomal protection protein gene [msr(E); conferring resistance to erythromycin and streptogramin B antibiotics] and a sulfonamide resistance gene (sul1; conferring resistance to sulfonamides). The complete genome of A. baumannii, strain MRSN 843 is available (GenBank: VHDU00000000).
Each vial contains approximately 0.5 mL of bacterial culture in Tryptic Soy broth supplemented with 10% glycerol.
Additional information and tools are available at PATRIC (Pathosystems Resource Integration Center).
Acinetobacter baumannii (A. baumannii), strain MRSN 843 was isolated in 2010 from a human wound sample in the United States as part of a global surveillance program.
A. baumannii, strain MRSN 843 was deposited as part of the MRSN Acinetobacter baumannii Diversity Panel available from BEI Resources as NR-52248. NR-52149 was deposited as multi-locus sequence type (MLST) ST 417, sensitive to amikacin, ampicillin/sulbactam, cefepime, ceftazidime, colistin and imipenem, intermediately resistant to ceftriaxone and tobramycin and resistant to ciprofloxacin, gentamicin, levofloxacin, meropenem, trimethoprim/sulfamethoxazole and tetracycline. Strain MRSN 843 is reported to have an aminoglycoside transferase gene [ant(2'')-Ia; conferring resistance to various aminoglycosides], two beta-lactamase genes (blaADC-25 and blaOXA-82; conferring resistance to beta-lactams), a chloramphenicol acetyltransferase gene (catB3; conferring resistance to chloramphenicol), a dihydrofolate reductase gene (dfrA19; conferring resistance to trimethoprim), a macrolide phosphotransferase gene [mph(E); conferring resistance to macrolides], an ABC-F type ribosomal protection protein gene [msr(E); conferring resistance to erythromycin and streptogramin B antibiotics] and a sulfonamide resistance gene (sul1; conferring resistance to sulfonamides). The complete genome of A. baumannii, strain MRSN 843 is available (GenBank: VHDU00000000).
Each vial contains approximately 0.5 mL of bacterial culture in Tryptic Soy broth supplemented with 10% glycerol.
Additional information and tools are available at PATRIC (Pathosystems Resource Integration Center).
主要内容
此项目的每个订单数量限制为1.此商品每年可订购两次.通过此限制的订单将在发货前发送到NIAID进行批准. acineTobacter baumannii（A. baumannii），在2010年从人类伤口中孤立MRSN 843美国的样本作为全球监督计划的一部分.
a. Baumannii ，将菌株MRSN 843作为MRSN 的一部分沉积，从BAUMANNIII 从BEI资源作为NR-52248获得的多样性面板. NR-52149沉积为多基因座序列类型（MLST）ST 417，对Amikacin，Ampicillin / Sulbactam，Cefepime，Ceftazidime，Colistin和Imipenem敏感，对Ceftriaxone和染发蛋白的中间抗性和抗Ciprofloxacin，庆大霉素，百氟葡葡聚糖，梅洛涅林， Trimethokim /磺胺甲恶唑和四环素.据报道菌株MRSN 843具有氨基糖苷转移酶基因[ant ant （2''） - Ia;赋予各种氨基糖苷的耐药性，两个β-内酰胺酶基因（ BLA ADC-25 和 BLA Oxa-82 ;赋予β-内酰胺的抗性），氯霉素乙酰转移酶基因（ B3;赋予氯霉素抗性），二氢醇还原酶基因（ DFRβ119;赋予Trimethokim耐药性） ，Macrolide phosphot转移酶基因[ mph （e）;赋予大溴化胶质剂的抗性，ABC-F型核糖体保护蛋白基因[ MSR （E）;赋予红霉素和链条B抗生素的抗性和磺酰胺抗性基因（SUL 1;赋予磺酰胺抗性）. a的完整基因组. Baumannii ，菌株MRSN 843可用（Genbank：）.
每个小瓶含有约0.5ml的胰蛋白酶肉汤中的细菌培养，补充有10％甘油.
patric （Pathosystems资源集成中心）提供了其他信息和工具.
厂牌介绍
BEI Resources 由美国国家过敏和传染病研究所 ( NIAID )成立，旨在为研究 A、B 和 C 类优先病原体、新兴传染病病原体、非病原微生物和其他相关微生物材料提供试剂、工具和信息到研究界。BEI Resources 获取、验证和生产科学家进行基础研究和开发改进的诊断测试、疫苗和疗法所需的试剂。通过将这些功能集中在 BEI Resources 中，可以监控科学界对这些材料的访问和使用，并确保试剂的质量控制。
除了为传染病界提供材料外，BEI Resources 还鼓励和支持研究人员和机构的材料存放。使用 BEI Resources存放材料对研究人员和研究社区有许多优势，包括安全存储、社区访问和分发；同时保护存款人的知识产权。只要有需要，BEI 资源库将作为研究人员的资源进行维护。您在 BEI Resources 的存款是一项有助于未来研究的长期投资。
BEI Resources 自 2003 年起由美国典型培养物保藏中心 (ATCC) 根据合同管理。2016 年 5 月， ATCC获得了一份为期七年的继续管理 BEI Resources的合同。合同范围已扩大到更全面的研究目录材料，包括由其他政府支持的研究项目存放的材料，将提供给生物防御和新兴传染病科学界。真菌、寄生虫、载体和其他相关材料已添加到现有的细菌、病毒和毒素试剂中，涵盖 NIAID A、B 和 C 类优先病原体和 NIAID 指定的新发传染病病原体和生物。
品牌标识
可能感兴趣的内容
2022-04-01
2022-04-01
2021-12-21
2024-09-22
2022-04-01
2024-10-20
2021-12-21
2022-03-31
2024-05-19
2022-04-01
2021-12-13
2024-06-25
2022-04-01